The findings and conclusions of this study are those of the authors and do not necessarily reflect the views of the Food and Drug Administration.
Research Article
The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D® 24-Hour—original formulation)†‡
Article first published online: 14 FEB 2003
DOI: 10.1002/pds.816
Copyright © 2003 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Manda, B., Drinkard, C. R., Shatin, D. and Graham, D. J. (2004), The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D® 24-Hour—original formulation). Pharmacoepidem. Drug Safe., 13: 29–34. doi: 10.1002/pds.816
- †
- ‡
Findings of this study were presented at the Annual Meeting of the Academy for Health Services Research and Policy, June 2001, Atlanta.
Publication History
- Issue published online: 24 DEC 2003
- Article first published online: 14 FEB 2003
- Manuscript Accepted: 22 NOV 2002
- Manuscript Revised: 19 AUG 2002
- Manuscript Received: 22 MAR 2002
Funded by
- US FDA Cooperative Agreement. Grant Number: FD-U-001643-01/02
- Abstract
- References
- Cited By
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)
1099-1557/asset/cover.gif?v=1&s=3d84b3516e1c56285d541e803f7d990de33f9824)